Grimes & Company, Inc. Abbott Laboratories Transaction History

Grimes & Company, Inc.

  • $3.43 Billion
  • Q4 2024

A detailed history of Grimes & Company, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Grimes & Company, Inc. holds 58,124 shares of ABT stock, worth $7.58 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
58,124
Previous 57,945 0.31%
Holding current value
$7.58 Million
Previous $6.61 Million 0.48%
% of portfolio
0.19%
Previous 0.18%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 21, 2025
BUY
$111.93 - $119.39 $20,035 - $21,370
179 Added 0.31%
58,124 $6.57 Million
Q3 2024

Oct 22, 2024
BUY
$100.07 - $118.13 $118,883 - $140,338
1,188 Added 2.09%
57,945 $6.61 Million
Q2 2024

Jul 22, 2024
SELL
$100.73 - $112.44 $22,059 - $24,624
-219 Reduced 0.38%
56,757 $5.9 Million
Q1 2024

Apr 17, 2024
SELL
$109.52 - $120.96 $6,352 - $7,015
-58 Reduced 0.1%
56,976 $6.48 Million
Q4 2023

Jan 24, 2024
BUY
$90.19 - $110.4 $223,761 - $273,902
2,481 Added 4.55%
57,034 $6.28 Million
Q3 2023

Oct 19, 2023
BUY
$95.53 - $114.62 $21,780 - $26,133
228 Added 0.42%
54,553 $5.28 Million
Q2 2023

Jul 19, 2023
SELL
$100.78 - $112.29 $13,605 - $15,159
-135 Reduced 0.25%
54,325 $5.92 Million
Q1 2023

Apr 20, 2023
BUY
$96.86 - $114.01 $1,937 - $2,280
20 Added 0.04%
54,460 $5.51 Million
Q4 2022

Jan 25, 2023
BUY
$95.06 - $111.52 $1,045 - $1,226
11 Added 0.02%
54,440 $0
Q3 2022

Oct 28, 2022
SELL
$96.76 - $112.03 $15,675 - $18,148
-162 Reduced 0.3%
54,429 $5.27 Million
Q2 2022

Jul 22, 2022
BUY
$102.07 - $123.37 $11,533 - $13,940
113 Added 0.21%
54,591 $5.93 Million
Q1 2022

May 06, 2022
BUY
$114.02 - $139.04 $1,596 - $1,946
14 Added 0.03%
54,478 $6.45 Million
Q4 2021

Feb 01, 2022
SELL
$115.53 - $141.46 $135,632 - $166,074
-1,174 Reduced 2.11%
54,464 $7.67 Million
Q3 2021

Nov 08, 2021
BUY
$116.66 - $129.06 $14,232 - $15,745
122 Added 0.22%
55,638 $6.57 Million
Q2 2021

Aug 04, 2021
SELL
$105.79 - $124.53 $10,367 - $12,203
-98 Reduced 0.18%
55,516 $6.44 Million
Q1 2021

May 12, 2021
BUY
$108.84 - $128.23 $867,999 - $1.02 Million
7,975 Added 16.74%
55,614 $6.67 Million
Q3 2020

Nov 12, 2020
SELL
$91.64 - $111.29 $1,008 - $1,224
-11 Reduced 0.02%
47,639 $5.19 Million
Q2 2020

Jul 31, 2020
BUY
$76.57 - $98.0 $4,517 - $5,782
59 Added 0.12%
47,650 $4.36 Million
Q1 2020

May 05, 2020
BUY
$62.82 - $91.86 $125,828 - $183,995
2,003 Added 4.39%
47,591 $3.76 Million
Q4 2019

Feb 05, 2020
BUY
$78.51 - $87.4 $12,404 - $13,809
158 Added 0.35%
45,588 $3.96 Million
Q3 2019

Nov 05, 2019
SELL
$81.84 - $88.74 $45,012 - $48,807
-550 Reduced 1.2%
45,430 $3.8 Million
Q2 2019

Jul 30, 2019
BUY
$72.88 - $85.0 $11,733 - $13,685
161 Added 0.35%
45,980 $3.87 Million
Q1 2019

May 02, 2019
SELL
$66.22 - $80.06 $2,582 - $3,122
-39 Reduced 0.09%
45,819 $3.66 Million
Q4 2018

Feb 01, 2019
SELL
$65.56 - $74.27 $6,228 - $7,055
-95 Reduced 0.21%
45,858 $3.32 Million
Q3 2018

Nov 09, 2018
SELL
$60.81 - $73.36 $8,087 - $9,756
-133 Reduced 0.29%
45,953 $3.37 Million
Q2 2018

Aug 10, 2018
BUY
$57.57 - $63.54 $43,177 - $47,655
750 Added 1.65%
46,086 $2.81 Million
Q1 2018

May 07, 2018
BUY
$56.27 - $63.62 $626,735 - $708,599
11,138 Added 32.57%
45,336 $2.72 Million
Q4 2017

Feb 05, 2018
BUY
$53.68 - $57.47 $1.62 Million - $1.73 Million
30,186 Added 752.39%
34,198 $1.95 Million
Q3 2017

Nov 03, 2017
BUY
$48.06 - $53.64 $192,816 - $215,203
4,012
4,012 $214,000

Others Institutions Holding ABT

# of Institutions
3,290
Shares Held
1.34B
Call Options Held
9.72M
Put Options Held
8.45M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $229B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Grimes & Company, Inc. Portfolio

Follow Grimes & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Grimes & Company, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email